XML 41 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidation
12 Months Ended
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidation
Consolidation

As of December 31, 2015, 13 products were consolidated by the Company including, 12 consolidated sponsored investment products and one consolidated investment product. As of December 31, 2014, 12 products were consolidated by the Company, comprised entirely of sponsored investment products.
The following tables reflect the impact of the consolidated sponsored investment products and consolidated investment product in the Consolidated Balance Sheets as of December 31, 2015 and December 31, 2014, respectively:
As of December 31, 2015
 
 
 
 
 
 
 
 
 
 
Balance Before
Consolidation of
Investment 
Products
 
Consolidated
Sponsored
Investment
Products
 
Consolidated
Investment
Products
 
Eliminations
and
Adjustments (a)
 
Balances as
Reported in
Consolidated
Balance  Sheet
($ in thousands)
 
 
 
 
 
 
 
 
 
Total cash
$
87,574

 
$
11,866

 
$
8,297

 
$

 
$
107,737

Total investments
349,147

 
323,335

 
199,485

 
(292,409
)
 
579,558

All other assets
162,673

 
8,549

 
1,467

 
(255
)
 
172,434

Total assets
$
599,394

 
$
343,750

 
$
209,249

 
$
(292,664
)
 
$
859,729

Total liabilities
$
89,937

 
$
15,642

 
$
171,084

 
$
(255
)
 
$
276,408

Redeemable noncontrolling interest

 

 

 
73,864

 
73,864

Equity attributable to stockholders of the Company
509,624

 
328,108

 
38,165

 
(366,273
)
 
509,624

Non-redeemable noncontrolling interest
(167
)
 

 

 

 
(167
)
Total liabilities and equity
$
599,394

 
$
343,750

 
$
209,249

 
$
(292,664
)
 
$
859,729


As of December 31, 2014
 
 
 
 
 
 
 
 
 
 
Balance Before
Consolidation of
Investment 
Products
 
Consolidated
Sponsored
Investment
Products
 
Consolidated
Investment
Products
 
Eliminations
and
Adjustments (a)
 
Balances as
Reported in
Consolidated
Balance  Sheet
($ in thousands)
 
 
 
 
 
 
 
 
 
Total cash
$
202,847

 
$
8,687

 
$

 
$

 
$
211,534

Total investments
279,863

 
236,652

 

 
(216,415
)
 
300,100

All other assets
180,436

 
6,960

 

 
(257
)
 
187,139

Total assets
$
663,146

 
$
252,299

 
$

 
$
(216,672
)
 
$
698,773

Total liabilities
$
99,794

 
$
12,813

 
$

 
$
(257
)
 
$
112,350

Redeemable noncontrolling interest

 

 

 
23,071

 
23,071

Equity attributable to stockholders of the Company
563,542

 
239,486

 

 
(239,486
)
 
563,542

Non-redeemable noncontrolling interest
(190
)
 

 

 

 
(190
)
Total liabilities and equity
$
663,146

 
$
252,299

 
$

 
$
(216,672
)
 
$
698,773

 
 
(a)
Adjustments include the elimination of intercompany transactions between the Company, its consolidated sponsored investment products and consolidated investment product, primarily the elimination of the investments, consolidated sponsored investment product equity, consolidated investment product equity and recording of any noncontrolling interest.

The following table reflects the impact of the consolidated sponsored investment products in the Consolidated Statement of Operations for the years ended December 31, 2015, 2014 and 2013, respectively:
 
 
For the Year Ended December 31, 2015
 
 
 
 
 
 
 
 
 
 
Balance  Before
Consolidation of
Investment 
Products
 
Consolidated
Sponsored
Investment
Products
 
Consolidated
Investment
Products
 
Eliminations
and
Adjustments (a)
 
Balances as
Reported in
Consolidated
Statement of
Operations
($ in thousands)
 
 
 
 
 
 
 
 
 
Total operating revenues
$
383,581

 
$

 
$

 
$
(1,604
)
 
$
381,977

Total operating expenses
297,465

 
5,738

 

 
(1,604
)
 
301,599

Operating income (loss)
86,116

 
(5,738
)
 

 

 
80,378

Total other non-operating expense
(14,214
)
 
(11,677
)
 
(1,832
)
 
14,988

 
(12,735
)
Income (loss) before income tax expense
71,902

 
(17,415
)
 
(1,832
)
 
14,988

 
67,643

Income tax expense
36,972

 

 

 

 
36,972

Net income (loss)
34,930

 
(17,415
)
 
(1,832
)
 
14,988

 
30,671

Noncontrolling interests
176

 

 

 
4,259

 
4,435

Net income (loss) attributable to common stockholders
$
35,106

 
$
(17,415
)
 
$
(1,832
)
 
$
19,247

 
$
35,106


 
For the Year Ended December 31, 2014
 
 
 
 
 
 
 
 
 
 
Balance Before
Consolidation of
Investment 
Products
 
Consolidated
Sponsored
Investment
Products
 
Consolidated
Investment
Products
 
Eliminations
and
Adjustments (a)
 
Balances as
Reported in
Consolidated
Statement of
Operations
($ in thousands)
 
 
 
 
 
 
 
 
 
Total operating revenues
$
451,259

 
$

 
$

 
$
(661
)
 
$
450,598

Total operating expenses
316,840

 
3,699

 

 
(661
)
 
319,878

Operating income (loss)
134,419

 
(3,699
)
 

 

 
130,720

Total other non-operating income (expense)
2,502

 
2,619

 

 
473

 
5,594

Income (loss) before income tax expense
136,921

 
(1,080
)
 

 
473

 
136,314

Income taxes
39,349

 

 

 

 
39,349

Net income (loss)
97,572

 
(1,080
)
 

 
473

 
96,965

Noncontrolling interests
128

 

 

 
607

 
735

Net income (loss) attributable to common stockholders
$
97,700

 
$
(1,080
)
 
$

 
$
1,080

 
$
97,700


For the Year Ended December 31, 2013
 
 
 
 
 
 
 
 
 
 
Balance  Before
Consolidation of
Investment 
Products
 
Consolidated
Sponsored
Investment
Products
 
Consolidated
Investment
Products
 
Eliminations
and
Adjustments (a)
 
Balances as
Reported in
Consolidated
Statement of
Operations
($ in thousands)
 
 
 
 
 
 
 
 
 
Total operating revenues
$
389,202

 
$

 
$

 
$
13

 
$
389,215

Total operating expenses
274,913

 
785

 

 
13

 
275,711

Operating income (loss)
114,289

 
(785
)
 

 

 
113,504

Total other non-operating income
5,620

 
6,098

 

 
(3,314
)
 
8,404

Income (loss) before income tax expense
119,909

 
5,313

 

 
(3,314
)
 
121,908

Income tax expense
44,778

 

 

 

 
44,778

Net income (loss)
75,131

 
5,313

 

 
(3,314
)
 
77,130

Noncontrolling interests
59

 

 

 
(1,999
)
 
(1,940
)
Net income (loss) attributable to common stockholders
$
75,190

 
$
5,313

 
$

 
$
(5,313
)
 
$
75,190

 
(a)
Adjustments include the elimination of intercompany transactions between the Company, its consolidated sponsored investment products and consolidated investment product, primarily the elimination of the investments, consolidated sponsored investment product equity, consolidated investment product equity and recording of any noncontrolling interest.